rs552478740

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000719.7(CACNA1C):​c.6001G>A​(p.Gly2001Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

1
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 1.08

Publications

3 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06362143).
BP6
Variant 12-2688663-G-A is Benign according to our data. Variant chr12-2688663-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 575699.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.6340G>A p.Gly2114Ser missense_variant Exon 49 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.6214G>A p.Gly2072Ser missense_variant Exon 47 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.6181G>A p.Gly2061Ser missense_variant Exon 46 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.6166G>A p.Gly2056Ser missense_variant Exon 47 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.6145G>A p.Gly2049Ser missense_variant Exon 48 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.6124G>A p.Gly2042Ser missense_variant Exon 46 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.6106G>A p.Gly2036Ser missense_variant Exon 47 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.6106G>A p.Gly2036Ser missense_variant Exon 47 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.6091G>A p.Gly2031Ser missense_variant Exon 46 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.6091G>A p.Gly2031Ser missense_variant Exon 46 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.6091G>A p.Gly2031Ser missense_variant Exon 46 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.6091G>A p.Gly2031Ser missense_variant Exon 46 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.6085G>A p.Gly2029Ser missense_variant Exon 47 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.6076G>A p.Gly2026Ser missense_variant Exon 47 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.6061G>A p.Gly2021Ser missense_variant Exon 47 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.6058G>A p.Gly2020Ser missense_variant Exon 46 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.6058G>A p.Gly2020Ser missense_variant Exon 46 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.6058G>A p.Gly2020Ser missense_variant Exon 46 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.6052G>A p.Gly2018Ser missense_variant Exon 46 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.6043G>A p.Gly2015Ser missense_variant Exon 46 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.6025G>A p.Gly2009Ser missense_variant Exon 45 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.6025G>A p.Gly2009Ser missense_variant Exon 45 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.6019G>A p.Gly2007Ser missense_variant Exon 45 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.6001G>A p.Gly2001Ser missense_variant Exon 46 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.5992G>A p.Gly1998Ser missense_variant Exon 46 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.5968G>A p.Gly1990Ser missense_variant Exon 45 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152190
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000566
AC:
14
AN:
247140
AF XY:
0.0000818
show subpopulations
Gnomad AFR exome
AF:
0.000132
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000716
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.0000342
AC:
50
AN:
1461296
Hom.:
0
Cov.:
33
AF XY:
0.0000385
AC XY:
28
AN XY:
726976
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33474
American (AMR)
AF:
0.0000224
AC:
1
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39692
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53164
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000324
AC:
36
AN:
1111778
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152308
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41560
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.0000580
AC:
7
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Timothy syndrome;C2678478:Brugada syndrome 3 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 30, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
CardioboostArm
Benign
0.0000020
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
14
DANN
Benign
0.76
DEOGEN2
Benign
0.017
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.085
N
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.064
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.26
T
PhyloP100
1.1
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.30
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Benign
0.27
Sift
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
0.27
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0, 0.0010, 0.26, 0.16, 0.43, 0.041
.;B;B;B;B;B;B;B;B;B;B;B;B;B;B;.;B;B;.;.;.;B;.
Vest4
0.20
MVP
0.43
MPC
0.19
ClinPred
0.013
T
GERP RS
0.97
gMVP
0.32
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552478740; hg19: chr12-2797829; COSMIC: COSV59776235; COSMIC: COSV59776235; API